corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

All items in the Healthy Skepticism Library

All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 146 of 206 pages ‹ First  < 144 145 146 147 148 >  Last ›

HSL1336
Anderson K.
Prices Of Most Popular Drugs For Seniors Rose Nearly Three-And-One-Half Times The Rate Of Inflation Last Year: Prices of 27 of the Top 50 Drugs Sold to Seniors Rose More Than Three Times the Rate of Inflation
Families USA 2003 Jul 9
http://www.familiesusa.org/resources/newsroom/press-releases/2002-press-releases/press-release-popular-prescription-drugs-for-seniors-rose-three-times-the-rate-of-inflation-last-year.html

HSL1337
Seaman B.
The Greatest Experiment Ever Performed on Women: Exploding the Estrogen Myth: Smart Doctors, Foolish Forecasts
MSNBC News 2003 Jul 9

HSL1338
Cronin J.
Corporate Money Co-opts Nonprofit Groups, Says Report Critics Silenced & Friends Won Through Corporate Donations
Center for Science in the Public Interest 2003 Jul 9
http://www.cspinet.org/new/200307092.html

HSL2066
Dana J, Loewenstein G.
A social science perspective on gifts to physicians from industry.
JAMA 2003 Jul 9;290:(2):252-5
http://jama.ama-assn.org/cgi/content/full/290/2/252

HSL18046
Walter G
Snapshot: “#$*%$#^* – it”!
MJA 2003 July 9;179:(11/12):670
http://www.mja.com.au/public/issues/179_11_011203/walter_snapshot_011203.html

HSL1332
Hallam K.
Medicare Drug Plans Can't Beat Canadian Prices, Retirees Say
Bloomberg News 2003 Jul 8

HSL1333
Bzdek V.
Tube Feeding: Health 'Education' Programs Are Beamed to the Hospital Bed by the Patient Channel. Some Critics Can't Swallow the Added Dose of Drug Company Promotion
Washington Post 2003 Jul 8

HSL1334
Pear R.
Democrats Lay Down Lines for Looming Medicare Fight
The New York Times 2003 Jul 8
http://www.nytimes.com/2003/07/09/us/democrats-lay-down-lines-for-looming-medicare-fight.html

HSL1331
Hallam K.
Frist, Hastert, Kennedy Battle Over Favoring Insurers, Medicare
Bloomberg News 2003 Jul 7

HSL10370
Chinellato A, Terrazzani G, Walley T, Giusti P.
Opioids in Italy: is marketing more powerful than the law?
Lancet 2003 Jul 5;362:(9377):78
http://linkinghub.elsevier.com/retrieve/pii/S0140673603138196

HSL18110
Yudkin P, Hey K, Roberts S, Welch S, Murphy M, Walton R.
Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch.
BMJ 2003 Jul 5;327:(7405):28-9
http://www.bmj.com/cgi/content/full/327/7405/28?view=long&pmid=12842953

HSL1330
Jack I.
Ottawa could permit prescription drug ads
National Post 2003 Jul 3

HSL1328
Goldstein A.
Bush to Name Ex-Lilly CEO to Run AIDS Fund: Praise and Skepticism for Major GOP Donor
Washington Post 2003 Jul 2

HSL1329
Lobe J.
Bush's look to Big Pharma for AIDS czar evokes concern
Asheville Global Report 2003 Jul 2

HSL1327
Knight B.
Eureka Foundation questions HRT research funding links
Australian Broadcasting Commission Radio National transcript 2003 Jul 1
http://www.abc.net.au/pm/content/2003/s892566.htm

HSL4938
Kabra SG.
Unsafe abortions and experimental excesses.
Issues Med Ethics 2003 Jul-Sep 01;11:(3):79-80

HSL5294
Casebeer LL, Strasser SM, Spettell CM, Wall TC, Weissman N, Ray MN, Allison JJ.
Designing tailored Web-based instruction to improve practicing physicians' preventive practices.
J Med Internet Res 2003 Jul-Sep 01;5:(3):e20
http://www.jmir.org/2003/3/e20/

HSL5301
Smith DH, Neutel JM, Lacourciere Y, Kempthorne-Rawson J.
Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements.
J Hypertens 2003 Jul 01;21:(7):1291-8
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0263-6352&volume=21&issue=7&spage=1291

HSL5345
Kuperman GJ, Gibson RF.
Computer physician order entry: benefits, costs, and issues.
Ann Intern Med 2003 Jul 1;139:(1):31-9
http://www.annals.org/cgi/reprint/139/1/31.pdf

HSL1178
Viale PH.
What nurse practitioners should know about direct-to-consumer advertising of prescription medications.
J Am Acad Nurse Pract 2003 Jul;15:(7):297-304

HSL1204
Hollon MF, Larson EB, Koepsell TD, Downer AE.
Direct-to-consumer marketing of osteoporosis drugs and bone densitometry.
Ann Pharmacother 2003 Jul-Aug;37:(7-8):976-81
http://www.theannals.com/cgi/content/full/37/7/976

HSL1219
Epps CH Jr.
Ethical guidelines for orthopaedists and industry.
Clin Orthop Relat Res 2003 Jul;(412):14-20
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0009-921X&volume=1&issue=412&spage=14

HSL1231
Chung RS, Taira DA, Noh C.
Alternate financial incentives in multi-tiered formulary systems to improve accountability for outcomes.
J Manag Care Pharm 2003 Jul-Aug;9:(4):360-5

HSL1254
[Publication standards for clinical research sponsored by the pharmaceutical industry]
Rev Panam Salud Publica 2003 Jul;14:(1):62-6

HSL1799
Wilson FS.
Continuing medical education: ethical collaboration between sponsor and industry.
Clin Orthop Relat Res 2003 Jul;(412):33-7

HSL4939
Kietinun S, Gupte MD, Sengupta A.
A clinical trial in a developing country: many questions, few answers.
Issues Med Ethics 2003 Jul-Sep;11:(3):89-90

HSL7348
Carpenter D, Chernew M, Smith DG, Fendrick AM.
Approval times for new drugs: does the source of funding for FDA staff matter?
Health Aff (Millwood) 2003 Jul-Dec;Suppl:
http://content.healthaffairs.org/cgi/reprint/hlthaff.w3.618v1

HSL10289
Nguyen VK, Grennan T, Peschard K, Tan D, Tiendrebeogo I.
Antiretroviral use in Ouagadougou, Burkina Faso.
AIDS 2003 Jul;17:
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0269-9370&volume=17&issue=&spage=S109

HSL10356
Antonanzas F.
Challenges to achieving value in drug spending in a decentralized country: the Spanish case.
Value Health 2003 Jul-Aug;6:

HSL10360
Sorensen L, King MA, Ientile CS, Roberts MS.
Has drug therapy gone to the dogs?
Age Ageing 2003 Jul;32:(4):460-1
http://ageing.oxfordjournals.org/cgi/reprint/32/4/460

HSL10361
Foley P.
Osteoporosis & Menopausal Disorders-SMi Conference.
IDrugs 2003 Jul;6:(7):660-3

HSL10362
Peck CC.
Postmarketing drug dosage changes.
Pharmacoepidemiol Drug Saf 2003 Jul-Aug;12:(5):425-6

HSL10373
Morrison CL, Kirk JM.
The consequences of parallel importing.
Br J Gen Pract 2003 Jul;53:(492):564
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=14694674

HSL10377
Domino ME, Salkever DS.
Price elasticity and pharmaceutical selection: the influence of managed care.
Health Econ 2003 Jul;12:(7):565-86
http://www3.interscience.wiley.com/cgi-bin/abstract/99015404/ABSTRACT?CRETRY=1&SRETRY=0

HSL18105
Reidpath DD.
'Love thy neighbour'-it's good for your health: a study of racial homogeneity, mortality and social cohesion in the United States.
Soc Sci Med 2003 Jul;57:(2):253-61
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-48M7NPD-2&_user=10&_coverDate=07/31/2003&_rdoc=1&_fmt=high&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0b67dee959e984a56a273ee56587654f

HSL18106
Abraham J, Reed T.
Reshaping the carcinogenic risk assessment of medicines: international harmonisation for drug safety, industry/regulator efficiency or both?
Soc Sci Med 2003 Jul;57:(2):195-204
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-47K2FVB-2&_user=10&_coverDate=07/31/2003&_rdoc=1&_fmt=high&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=2fe98ef29b4b809b0cfa04b1bc768e52

HSL18108
Healy D, Cattell D.
Interface between authorship, industry and science in the domain of therapeutics.
Br J Psychiatry 2003 Jul;183:22-7:
http://bjp.rcpsych.org/cgi/content/full/183/1/22

HSL19919
Metzl JM, Riba M
Understanding the Symbolic Value of Medications: A Brief Review
Primary Psychiatry 2003 July;10:(7):45-48

HSL1322
Carey B.
Psychiatry and preschoolers: More young children are being diagnosed with mental ailments and treated with drugs even as doctors grapple with a lack of research.
Los Angeles Times 2003 Jun 30

HSL1323
Guyatt G.
Evidence-based medicine challenges accepted medical practices: Doctors have not been taught how to evaluate original research or help patients weigh up the benefits, and risks, of alternative therapies
Straight Goods 2003 Jun 30

HSL1325
Pugh T.
Medical TV channel challenged over ethics: The Patient Channel blurs the line between advertising and patient education, critics say.
The Philadelphia Inquirer 2003 Jun 30

HSL1319
Petersen M.
Who's Minding the Drugstore?
The New York Times 2003 Jun 29
http://www.nytimes.com/2003/06/29/business/who-s-minding-the-drugstore.html

HSL1320
Feinmann J.
Tricks of the trade: Extravagant freebies, insider 'experts' and biased research... Should we be concerned about the way the pharmaceutical industry woos our GPs?
The Observer 2003 Jun 29
http://www.guardian.co.uk/theobserver/2003/jun/29/features.magazine47

HSL1321
Kowalczyk L.
Hospital, drug firm relations probed
The Boston Globe 2003 Jun 29

HSL1318
Burton B.
Gov't wants drug companies to reveal doctors junkets
Inter-Press Service 2003 Jun 28

HSL1316
Anderson T.
Just what the doctor ordered: Reforms passed a year ago have changed the way drug reps deal with docs
Baltimore Business Journal 2003 Jun 27

HSL1317
Goldstein A
Medicare Bills Would Add Drug Benefits: Prescription Drug Benefit Is Key To Biggest Changes in 38 Years
The Washington Post 2003 Jun 27

HSL1314
Hussain A.
115 brands of 32 essential drugs missing in the market
Daily Dawn 2003 Jun 26

HSL1315
Medicines watchdog under fire
BBC NEWS 2003 Jun 26
http://news.bbc.co.uk/2/hi/health/3021082.stm

HSL1313
Government "discusses" drug safety with corporation
Monday Magazine 2003 Jun 25

HSL18116
Mitka M.
Accelerated approval scrutinized: confirmatory phase 4 studies on new drugs languish.
JAMA 2003 Jun 25;289:(24):3227-9
http://jama.ama-assn.org/cgi/content/full/289/24/3227

HSL18118
Egilman DS, Ehrle LH.
Handling conflicts of interest between industry and academia.
JAMA 2003 Jun 25;289:(24):3240
http://jama.ama-assn.org/cgi/content/full/289/24/3240

HSL1309
Pharmaceuticals: Focussing on Appropriate Utilization: Drug Prescribing In Manitoba: How Appropriate Is It?
The Manitoba Centre for Health Policy 2003 Jun 24

HSL1310
Freudenheim M.
U.S. Accuses Merck Unit of Cheating Health Plan
New York Times 2003 Jun 24
http://www.nytimes.com/2003/06/24/business/us-accuses-merck-unit-of-cheating-health-plan.html

HSL1311
Koppel N.
U.S. Drops its Demand for List of Diseases Covered by Drugs Agreement
Centers for Disease Control and Prevention. 2003 Jun 24

HSL4481
Mansfield PR, Mak HK.
Drug reps: friend or foe?
Australian Doctor Weekly 2003 Jun 24

HSL1307
Cassles A.
Don't gamble with our drug prices
2003 Jun 23

HSL1308
Drug Industry Employs 675 Washington Lobbyists, Many with Revolving-Door Connections, New Report Finds
Public Citizen 2003 Jun 23

HSL5341
Kaushal R, Shojania KG, Bates DW.
Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review.
Arch Intern Med 2003 Jun 23;163:(12):1409-16
http://archinte.ama-assn.org/cgi/content/full/163/12/1409

HSL1305
Harvey L.
Anthrax vaccine a deadly defense?: Critics say military's anthrax vaccination is medically hazardous and unethical
NW Indiana Times 2003 Jun 22

HSL1306
Kowalczyk L.
Cost and consequence: Medicaid aims to curb 'poly-pharmacy' approach, but drug limits may undermine patients' health
The Boston Globe 2003 Jun 22

HSL1303
Petersen M.
AstraZeneca Pleads Guilty in Cancer Medicine Scheme
The New York Times 2003 Jun 21
http://www.nytimes.com/2003/06/21/business/astrazeneca-pleads-guilty-in-cancer-medicine-scheme.html

HSL1304
Cure For The Common Cold
British Medical Journal 2003 Jun 21

HSL18119
Eaton L
Readers want transparency in link between doctors and drug firms
BMJ 2003 Jun 21;326:(7403):1352
http://www.bmj.com/cgi/content/full/326/7403/1352-a

HSL1302
Bouchez C.
Pills That Promise More Than Just Birth Control
HealthDay 2003 Jun 20

HSL1299
Competition Bureau will investigate big drug firm
National Union of Public and General Employees 2003 Jun 19

HSL1300
The Other Drug War
Frontline 2003 Jun 19
http://www.pbs.org/wgbh/pages/frontline/shows/other/

HSL1301
McCall R.
Paxil Victims React to FDA's Announcement re Suicide Risk in Children Attorneys Representing Thousands of Paxil Victims Respond
Baum, Hedlund, Aristei, Guilford & Schiavo 2003 Jun 19

HSL1295
Japsen B.
AMA says drug reps not welcome in exams
Chicago Tribune 2003 Jun 18

HSL1297
Cordon S.
Lift ban on drug ads, newspaper group says
The Windsor Star 2003 Jun 18

HSL1298
Dixon K.
Doctors vote to curb pharmaceutical reps in office
Reuters Health 2003 Jun 18

HSL1312
Regush N.
Shame On You, American Medical Association
Red Flags 2003 Jun 18
http://web.archive.org/web/20071014161434/http://www.redflagsweekly.com/second_opinion_m.html

HSL1291
Davies J.
Accidental addicts
The Age 2003 Jun 16

HSL1292
Rosen R.
Profitable pills in search of a disease
San Francisco Chronicle 2003 Jun 16
http://articles.sfgate.com/2003-06-16/opinion/17494840_1_hormone-therapy-drug-industry-control-pills

HSL1293
Serkes K.
Doctors Win Supreme Court Decision To Halt Forced Drugging
2003 Jun 16

HSL1294
New antibiotics 'could prove deadly'
BBC News 2003 Jun 16
http://news.bbc.co.uk/2/hi/health/2994528.stm

HSL17955
Cloutier-Steele L
Superfluous surgery?
The Washington Post 2003 Jun 15

HSL1290
Templeton S.
Drug firm's obesity 'advert' should be banned, say GPs
The Sunday Herald 2003 Jun 15

HSL1289
National Union seeks probe of big drug companies
National Union of public and general employees 2003 Jun 14

HSL18120
Waechter F.
Paroxetine must not be given to patients under 18.
BMJ 2003 Jun 14;326:(7402):1282
http://www.bmj.com/cgi/content/full/326/7402/1282-b?view=long&pmid=12805134

HSL18121
Ford N.
Public health and company wealth.
BMJ 2003 Jun 14;326:(7402):1296
http://www.bmj.com/cgi/content/full/326/7402/1296?view=long&pmid=12805159

HSL18122
Prentice P.
Make the most of your doctor.
BMJ 2003 Jun 14;326:(7402):1292
http://www.bmj.com/cgi/content/full/326/7402/1292?view=long&pmid=12805148

HSL18123
Watson R.
EU health ministers reject proposal for limited direct to consumer advertising.
BMJ 2003 Jun 14;326:(7402):1284
http://www.bmj.com/cgi/content/full/326/7402/1284-b?view=long&pmid=12805139

HSL18124
Kmietowicz Z.
New Zealand GPs call for end to direct to consumer advertising.
BMJ 2003 Jun 14;326:(7402):1284
http://www.bmj.com/cgi/content/full/326/7402/1284-c?view=long&pmid=12805140

HSL1286
Hensley S.
As Drug-Sales Teams Multiply, Doctors Start to Tune Them Out 'Arms Race' by Pfizer and Rivals Boosts Pill Prices, Ire, but No One Dares Retreat
The Wall Street Journal 2003 Jun 13

HSL1287
Elliott C.
Pill Pushovers: Katherine Greider's The Big Fix looks at the pharmaceutical industry's hold on doctors
The American Prospect 2003 Jun 13
http://www.prospect.org/cs/articles?article=pill_pushovers

HSL1288
Jensen J.
Let's Not Medicate Away Student Angst
The Chronicle of Higher Education 2003 Jun 13
http://chronicle.com/article/Lets-Not-Medicate-Away/24644/

HSL1284
Rowland C.
Drug ads deliver a few side effects: Firms reap rewards, but so do their rivals, and patients take data to the doc, study finds
The Boston Globe 2003 Jun 12

HSL1285
Deadly clinical trial wasn't approved by Health Canada
CBC Radio 2003 Jun 12
http://www.cbc.ca/canada/ottawa/story/2003/06/12/ot_lucio20030612.html

HSL11660
Garlick W.
Head to head: Should drug companies be allowed to talk directly to patients? NO
BMJ 2003 Jun 12;326:(7402):1302
http://www.bmj.com/cgi/content/full/326/7402/1302-a

HSL11661
Jones T.
Head to head: Should drug companies be allowed to talk directly to patients? YES
BMJ 2003 Jun 12;326:(7402):1302
http://www.bmj.com/cgi/content/full/326/7402/1302

HSL18125
Silversides A
Trials and tribulation as research moves into the community
CMAJ 2003 Jun 12;
http://www.cmaj.ca/news/12_06_03.dtl

HSL1280
Harris G.
Britain Says Use of Paxil by Children Is Dangerous
The New York Times 2003 Jun 11
http://www.nytimes.com/2003/06/11/business/britain-says-use-of-paxil-by-children-is-dangerous.html?scp=177&sq=&st=nyt

HSL1281
Boseley S.
Mood drug Seroxat banned for under-18s
The Guardian 2003 Jun 11
http://www.guardian.co.uk/science/2003/jun/11/sciencenews.medicineandhealth

HSL1282
Vedantam S
Britain Warns of Paxil's Risk to Children
The Washington Post 2003 Jun 11

HSL1278
Laurance J.
Seroxat to be restricted over fears of suicide link
The Independent 2003 Jun 10
http://www.antidepressantsfacts.com/2003-06-10-independent.htm

HSL1279
Seroxat Must Not Be Used For Treatment Of Children With Depression
Department of Health 2003 Jun 10

HSL17940
Boseley S
Seroxat warning over risk to young Suicidal feelings may be side effect for under-18s
The Guardian 2003 Jun 10

HSL1272
Cobb C.
U.S. drug firms want subsidies ended in Canada: Lobbying against medicare
National Post 2003 Jun 9

HSL1273
U.S. Drug Industry Steps Up Lobbying In Canada
CanWest News Service, 2003 Jun 9

Page 146 of 206 pages ‹ First  < 144 145 146 147 148 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.